Search Within

Population Sciences Research Program

  1. "Biomed Central Ltd"
  2. "Solid Tumor Oncology Division"
  3. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (21)
  2. Epidemiology and Biostatistics (21)
  3. Solid Tumor Oncology Division (21)
  4. Biostatistics Service (20)
  5. GSK Faculty (15)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)

More Groups

People
  1. Katherine Panageas (10)
  2. Jedd Wolchok (8)
  3. Mark Robson (5)
  4. Paul Chapman (4)
  5. Ronglai Shen (4)
  6. Anne Reiner (3)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (2)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (11)
  2. Breast Cancer Research (4)
  3. BMC Genetics (1)
  4. BMC Medical Genetics (1)
  5. Cardio-Oncology (1)
  6. Genome Biology (1)

More Publications

Publishers
  1. Biomed Central Ltd (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
    Journal Article

    Yu, A. F.; Dang, C. T.; Jorgensen, J.; Moskowitz, C. S.; DeFusco, P.; Oligino, E.; Oeffinger, K. C.; Liu, J. E.; Steingart, R. M.
    Cardio-Oncology (2023)

    Fulltext@MSK | Save
  • Uncovering the hidden structure of T cell compositions in peripheral blood after immune checkpoint inhibitor
    Meeting Abstract

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Callahan, M.; Panageas, K.; Shen, R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save